Introduction
Opportunistic infections by fungal, bacterial, viral, and protozoal organisms are being reported in everincreasing frequency. Of the mycotic infections, aspergillosis, candidiasis, mucormycosis, histoplasmosis, nocardiasis and cryptococcosis have been implicated. Patients with lymphoproliferative and immune deficiency disorders such as Hodgkin's disease, other lymphomas, leukaemias, multiple myeloma, primary and acquired agammaglobulinaemia and even Boeck's sarcoid seem particularly vulnerable. This susceptibility seems to derive primarily from a defective defence mechanism which characterizes these diseases, but in our current era of aggressive and intensive therapy, their treatment with immunosuppressive agents, e.g. corticosteroids, cytotoxic drugs and ionizing radiation, encourages these unusual, serious complicating infections. In this context SLE may also be viewed as a disease of abnormal immune reactivity and tolerance, and its increased susceptibility to opportunistic fungal infections, particularly when accentuated by steroid therapy, should not be surprising. This was soon confirmed by culture. Amphotericin-B therapy was instituted in an initial dose of 10 mg dissolved in 400 cc of 5 % dextrose in water with 40 mg hydrocortisone and 1000 u heparin i.v. infusion over a period of 6 hr. Therapy was continued on alternate day basis, increasing the dose by 10 mg each time during the first week, and later by 5 mg until the maximum dose of 35 mg (0-75 mg/kg) was reached. By using alternate limb veins for each infusion, no local complications of therapy were encountered. One week after initiation of therapy, the patient was able to communicate and to consume liquids. Head- The initial few weeks of therapy were attended with elevation of LDH and alkaline phosphatase to levels of 515 u and 275 u respectively (with normal bilirubin) followed by a slow fall towards normal even as treatment with amphotericin was continued.
The patient received a total of 1 g amphotericin-B over a 4-month period. This resulted in complete remission of constitutional and neurological symptoms, allowing him to return to work. Since discontinuation of therapy, three spinal taps (Table 1) have failed to document any residual infection. This would seem to attest to the adequacy of a relatively small dose of amphotericin-B in eradicating infection in this patient, perhaps because of his low body weight (90 lb). The recommended total dose of about 3 g should be adhered to in standard situations.
Discussion
Cryptococcal involvement of the central nervous system (CNS) is usually insidious in onset producing signs and symptoms of meningitis, meningoencephalitis, or a space-occupying lesion. Headaches are generally followed by slowly progressive malaise, depression, disorientation and fever with eventual appearance of nausea, vomiting, nuchal rigidity and other manifestations of elevated intracranial tension. Untreated cryptococcal meningitis usually terminates fatally within several months, although chronic infection lasting many years has been described.
The incidence of cryptococcal meningitis is relatively high in patients with Hodgkin's disease, lymphoma, leukaemia, diabetes mellitus, and also in those on long-term steroid therapy (Zimmerman and Rappaport, 1954) . That C. neoformans is not an infrequent culprit in the aforementioned diseases is also attested to by Goldstein and Rambo's (1962) report of 286 cryptococcal infections. Almost 10% of their cases had reticuloendothelial malignancies and 5*4% had had prior steroid therapy. On the other hand, complete absence of cryptococcal infection in an analysis of 520 cases of SLE by Dubois and Tuffanelli (1964) and the report of only one such complication in Harvey's 138 SLE cases (Harvey, 1954) leads one to conclude that this mycotic disease is a rather rare development in this setting. Nevertheless, we have been able to find six previously reported cases of SLE with this infection, summarized in Table 2 .
In our perusal of the literature, we also found reference to several other patients with cryptococcal infection in which background clinical features suggested active SLE. Failure to perform LE preparation, etc., indicates that the diagnosis was not given serious consideration. Nicholas and Martin in 1955 described such a case in a 16-year-old girl with fever, headache, malar flush, generalized lymphadenopathy, leukopenia, microscopic haematuria and EKG changes suggestive of pericarditis. At postmortem examination 6 weeks later disseminated cryptococcosis was found. CNS manifestations in the patient of Pariser, Littman and Duffy (1961) , in retrospect, were obviously due to cryptococcal meningitis but were misinterpreted as representing cerebral vasculitis of SLE. The confusion is understandable when it is realized that many CNS symptoms of these two disorders are similar. Over 25% of patients with SLE present CNS involvement in the form of headaches, irritability, psychosis, meningismus seizure, etc. (Dubois and Tuffanelli, 1964) . Of fifty-eight SLE cases reported by Dubois (1956) , 25 (43 1 %) died of progressive CNS disease despite adequate steroid therapy. Twenty-seven of these fifty-eight were not autopsied, and cause of death was determined merely by a study of their terminal course. It is conceivable that a small number might have died of cryptococcal meningitis instead of so-called terminal CNS lupus. Lack of awareness of this possibility could lead one to employ even larger doses of steroids and perhaps additional immunosuppressive agents, with obviously disastrous consequences.
It should be noted that of seven patients (including our own), five had been receiving steroid therapy for periods ranging from a few weeks to several years before the infection apparently developed. In the remaining two, cryptococcal infection appeared spontaneously and treatment with prednisone for what was considered to be lupus cerebral vasculitis may have led to progressive deterioration of their condition.
Of particular importance is the fact that in five of the six cases previously reported, cryptococcal infection was not suspected, not treated and was the cause of death. 
